anmeldenNovo Nordisk Aktie
38,97
EUR
-0,39
EUR
-0,99
%
39,18
EUR
-0,23
EUR
-0,57
%
Novo Nordisk jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Marktkap. 174,75 Mrd. EUR
KGV 14,11 Div. Rendite 3,60%WKN A3EU6F
ISIN DK0062498333
Symbol NONOF
AI Analyse
Werbung
Novo Nordisk Aktie Analyse
| 25.04.18 | Novo Nordisk buy | UBS AG | |
| 18.04.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.04.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 27.03.18 | Novo Nordisk buy | UBS AG | |
| 23.02.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 22.02.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.02.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.02.18 | Novo Nordisk buy | UBS AG | |
|
Werbung
|
|||
| 07.02.18 | Novo Nordisk buy | UBS AG | |
| 02.02.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 02.02.18 | Novo Nordisk buy | UBS AG | |
| 02.02.18 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 02.02.18 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.02.18 | Novo Nordisk buy | UBS AG | |
| 19.01.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.01.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 15.01.18 | Novo Nordisk buy | UBS AG | |
| 12.01.18 | Novo Nordisk buy | UBS AG | |
| 09.01.18 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 09.01.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 08.01.18 | Novo Nordisk buy | UBS AG | |
| 12.12.17 | Novo Nordisk buy | UBS AG | |
| 06.12.17 | Novo Nordisk overweight | Morgan Stanley | |
| 06.12.17 | Novo Nordisk buy | UBS AG | |
| 06.12.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 06.12.17 | Novo Nordisk buy | Merrill Lynch & Co., Inc. | |
| 06.12.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.12.17 | Novo Nordisk overweight | Morgan Stanley | |
| 28.11.17 | Novo Nordisk buy | UBS AG | |
| 22.11.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 02.11.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 02.11.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.11.17 | Novo Nordisk buy | UBS AG | |
| 23.10.17 | Novo Nordisk buy | UBS AG | |
| 17.10.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 17.10.17 | Novo Nordisk buy | UBS AG | |
| 09.10.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 18.08.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 17.08.17 | Novo Nordisk buy | UBS AG | |
| 17.08.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 10.08.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 10.08.17 | Novo Nordisk buy | UBS AG | |
| 10.08.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.08.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 01.08.17 | Novo Nordisk buy | UBS AG | |
| 26.07.17 | Novo Nordisk buy | UBS AG | |
| 07.07.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 14.06.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 12.06.17 | Novo Nordisk buy | UBS AG | |
| 26.05.17 | Novo Nordisk buy | Deutsche Bank AG | |
Werbung
Werbung
